Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Enanta Pharmaceuticals (ENTA) Assets Average (2016 - 2025)

Historic Assets Average for Enanta Pharmaceuticals (ENTA) over the last 13 years, with Q4 2025 value amounting to $305.1 million.

  • Enanta Pharmaceuticals' Assets Average fell 1586.38% to $305.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $305.1 million, marking a year-over-year decrease of 1586.38%. This contributed to the annual value of $328.7 million for FY2025, which is 2163.99% down from last year.
  • Enanta Pharmaceuticals' Assets Average amounted to $305.1 million in Q4 2025, which was down 1586.38% from $290.9 million recorded in Q3 2025.
  • In the past 5 years, Enanta Pharmaceuticals' Assets Average registered a high of $478.7 million during Q3 2023, and its lowest value of $290.9 million during Q3 2025.
  • Moreover, its 5-year median value for Assets Average was $401.1 million (2022), whereas its average is $393.6 million.
  • Per our database at Business Quant, Enanta Pharmaceuticals' Assets Average surged by 2587.61% in 2023 and then crashed by 2497.99% in 2025.
  • Enanta Pharmaceuticals' Assets Average (Quarter) stood at $439.7 million in 2021, then decreased by 17.79% to $361.5 million in 2022, then grew by 23.21% to $445.4 million in 2023, then fell by 18.58% to $362.6 million in 2024, then decreased by 15.86% to $305.1 million in 2025.
  • Its Assets Average was $305.1 million in Q4 2025, compared to $290.9 million in Q3 2025 and $312.0 million in Q2 2025.